Literature DB >> 11475440

Ring-enchancement in multiple sclerosis: marker of disease severity.

K Morgen1, N O Jeffries, R Stone, R Martin, N D Richert, J A Frank, H F McFarland.   

Abstract

Correlations between conventional MRI measures of disease activity and clinical disability in multiple sclerosis (MS) have been disappointing. Because ring-enhancing lesions may reflect a more destructive pathology, we tested their potential association with disease severity. We evaluated active lesions with regard to their enhancement pattern on serial magnetic resonance images in a cohort of 28 patients with relapsing-remitting MS. The percentage of ring-enhancing lesions correlated with EDSS, T2 lesion load and duration of disease and predicted the occurrence of relapses during the baseline period of observation as well as after 3 years of follow-up in multiple logistic regression analysis. The findings suggest that the pathological process reflected by ring-enhancing lesions may contribute to more severe clinical disease.

Entities:  

Mesh:

Year:  2001        PMID: 11475440     DOI: 10.1177/135245850100700306

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Ring and nodular multiple sclerosis lesions: a retrospective natural history study.

Authors:  M Davis; S Auh; M Riva; N D Richert; J A Frank; H F McFarland; F Bagnato
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

2.  Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.

Authors:  María I Gaitán; Colin D Shea; Iordanis E Evangelou; Roger D Stone; Kaylan M Fenton; Bibiana Bielekova; Luca Massacesi; Daniel S Reich
Journal:  Ann Neurol       Date:  2011-06-27       Impact factor: 10.422

3.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

4.  Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.

Authors:  María I Gaitán; Pascal Sati; Souheil J Inati; Daniel S Reich
Journal:  Mult Scler       Date:  2012-12-17       Impact factor: 6.312

5.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.

Authors:  E Mark Haacke; Malek Makki; Yulin Ge; Megha Maheshwari; Vivek Sehgal; Jiani Hu; Madeswaran Selvan; Zhen Wu; Zahid Latif; Yang Xuan; Omar Khan; James Garbern; Robert I Grossman
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

Review 6.  Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.

Authors:  Rachel Babij; Jai S Perumal
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-18       Impact factor: 2.570

7.  Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.

Authors:  Mark D Kvarta; Deva Sharma; Rudolph J Castellani; Robert E Morales; Stephen G Reich; Amy S Kimball; Robert K Shin
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.